Omidubicel currently has an FDA Breakthrough Designation which is "process designed to expedite the development and review of drugs that are intended to treat a serious condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapy on a clinically significant endpoint" Basically, this means...
Along with BTC breakout, Ethereum is also breaking out of weekly Camarilla resistance. If price follows the current channel, then price target is roughly +45% above current price.
American Well Corp is telehealth. Today they were blasted with upgrades/coverage from 7 different firms, ranging in price target from $29-$44. I personally think that the pandemic has already created the environment for people to steadily transition from face/face interactions when it comes to routine chores.
Leading lidar technology (robot eyes) for automated vehicles Projected revenue to increase by 34% in 2021, +53% by 2022, +71% by 2023 Total 16 multi year contracts
Very nice breakout wedge setting up here in DOT/USDT on Binance. Classic shape.
Things are looking bullish for BTC-- which means that it will be bullish for alts as well.
Timeline to correlate periods of social unrest due to the use of deadly force by police. Unrest due to political ideology (Occupy Movement) had no effect on UONE stock price. Periods of relative peace also had no effect on stock price. Riots that resulted from sporting events were not included in this analysis.
The price spike on Aug 20th was due to a long-term deal worth $1.5B USD. Following that, an intellectual property firm valued GEVO's IP at over $400M. Considering GEVO's market cap at 61M; the 400M valuation would mean that this stock is undervalued and should be around the $5 mark.
XSPA is another company that relies on the airline industry. Currently, it is in the process of reinventing itself by becoming the COVID testing solution for major airports. If we can assume that the virus is not going away and XSPA keeps expanding to as many airports as possible, then there might be a future for this beat down stock. In August, XSPA raised $35M...
LOL. Check this out: During the month of July, 11 different law firms filed class action lawsuits against SRNE. Afterwards, the price rallied 125%. Or maybe it rallied because SRNE announced the start of phase 2 trials on one of their drugs? I think the lawsuits gave this company more exposure than the phase 2 trials alone. Currently in Phase 1 of COVID antibody...
Emergent BioSolutions is well known for owning the rights to the pioneering technology behind the Narcan nasal spray. Naloxone has been around for years as an injectable for opioid overdoses which required expertise to administer. Narcan spray eliminated the expertise requirement. Recently, EBS entered into several large contracts with giant pharma and will...
This stock had 100M volume today-- which is unusual, therefore significant. I did some forensic analysis of their news and it appears that they had a phase 3 survival events failure which means that the meds they were testing did not increase the chances of survival among cancer patients. Now they start over again (Phase 1) on their other cancer drugs. I...
This is a timeline of funding related to the US Government's Operation Warp Speed. MRNA and NVAX are the two stocks that have reacted strongly (in both directions) to any kind of COVID news. You can see that towards the end of phase 1 trials, they disclosed grade 3 adverse reactions to the vaccine which led to a -50% drop in the stock.
EVOK has an analyst sell target at $10. I believe that with a float of 24M, this stock has the stock characteristics to hit $10 and maybe even further. And why is it positive when everything else is down???
Citigroup upgrade sell target to $112 as of August 27th 2020. I have targets just under $100 and again at $125+
probably one of the strongest stocks I've seen. Company is not in debt! and sitting on tons of cash!
Momentum is starting to build and I am anticipating a second and third leg up with goal at $10. This plan is contingent upon Monday follow-through with the yellow arrow; else red arrow and abandon.